Annual EBITDA
$43.25 M
+$33.01 M+322.43%
31 December 2023
Summary:
Cellebrite DI annual earnings before interest, taxes, depreciation & amortization is currently $43.25 million, with the most recent change of +$33.01 million (+322.43%) on 31 December 2023. During the last 3 years, it has risen by +$28.15 million (+186.47%). CLBT annual EBITDA is now at all-time high.CLBT EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly EBITDA
$22.07 M
+$120.06 M+122.52%
30 September 2024
Summary:
Cellebrite DI quarterly earnings before interest, taxes, depreciation & amortization is currently $22.07 million, with the most recent change of +$120.06 million (+122.52%) on 30 September 2024. Over the past year, it has increased by +$6.21 million (+39.14%). CLBT quarterly EBITDA is now -83.29% below its all-time high of $132.06 million, reached on 31 December 2022.CLBT Quarterly EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM EBITDA
-$155.04 M
+$6.21 M+3.85%
30 September 2024
Summary:
Cellebrite DI TTM earnings before interest, taxes, depreciation & amortization is currently -$155.04 million, with the most recent change of +$6.21 million (+3.85%) on 30 September 2024. Over the past year, it has dropped by -$312.74 million (-198.32%). CLBT TTM EBITDA is now -198.32% below its all-time high of $157.69 million, reached on 30 September 2023.CLBT TTM EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
CLBT EBITDA Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +322.4% | +39.1% | -198.3% |
| 3 y3 years | +186.5% | +2317.8% | -757.7% |
| 5 y5 years | - | - | - |
CLBT EBITDA High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | at high | +322.4% | -83.3% | +122.5% | -198.3% | +3.9% |
| 5 y | 5 years | at high | +1590.0% | -83.3% | +122.5% | -198.3% | +3.9% |
| alltime | all time | at high | +1590.0% | -83.3% | +122.5% | -198.3% | +3.9% |
Cellebrite DI EBITDA History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | $22.07 M(-122.5%) | -$155.04 M(-3.8%) |
| June 2024 | - | -$97.99 M(-921.6%) | -$161.25 M(+187.6%) |
| Mar 2024 | - | $11.93 M(-113.1%) | -$56.07 M(-14.3%) |
| Dec 2023 | $43.25 M(+322.4%) | -$91.05 M(-674.1%) | -$65.41 M(-141.5%) |
| Sept 2023 | - | $15.86 M(+120.5%) | $157.69 M(+10.2%) |
| June 2023 | - | $7.19 M(+178.4%) | $143.05 M(+7.9%) |
| Mar 2023 | - | $2.58 M(-98.0%) | $132.52 M(+1.9%) |
| Dec 2022 | $10.24 M | $132.06 M(>+9900.0%) | $130.10 M(+78.9%) |
| Sept 2022 | - | $1.22 M(-136.5%) | $72.72 M(+3.1%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| June 2022 | - | -$3.34 M(-2113.3%) | $70.50 M(-15.8%) |
| Mar 2022 | - | $166.00 K(-99.8%) | $83.76 M(-6.4%) |
| Dec 2021 | $20.83 M(+38.0%) | $74.67 M(-7604.7%) | $89.47 M(+279.5%) |
| Sept 2021 | - | -$995.00 K(-110.0%) | $23.57 M(-33.1%) |
| June 2021 | - | $9.92 M(+69.0%) | $35.24 M(+23.7%) |
| Mar 2021 | - | $5.87 M(-33.2%) | $28.49 M(+25.9%) |
| Dec 2020 | $15.10 M(+490.0%) | $8.78 M(-17.7%) | $22.62 M(+63.4%) |
| Sept 2020 | - | $10.67 M(+236.5%) | $13.84 M(+336.5%) |
| June 2020 | - | $3.17 M | $3.17 M |
| Dec 2019 | $2.56 M | - | - |
FAQ
- What is Cellebrite DI annual earnings before interest, taxes, depreciation & amortization?
- What is the all time high annual EBITDA for Cellebrite DI?
- What is Cellebrite DI annual EBITDA year-on-year change?
- What is Cellebrite DI quarterly earnings before interest, taxes, depreciation & amortization?
- What is the all time high quarterly EBITDA for Cellebrite DI?
- What is Cellebrite DI quarterly EBITDA year-on-year change?
- What is Cellebrite DI TTM earnings before interest, taxes, depreciation & amortization?
- What is the all time high TTM EBITDA for Cellebrite DI?
- What is Cellebrite DI TTM EBITDA year-on-year change?
What is Cellebrite DI annual earnings before interest, taxes, depreciation & amortization?
The current annual EBITDA of CLBT is $43.25 M
What is the all time high annual EBITDA for Cellebrite DI?
Cellebrite DI all-time high annual earnings before interest, taxes, depreciation & amortization is $43.25 M
What is Cellebrite DI annual EBITDA year-on-year change?
Over the past year, CLBT annual earnings before interest, taxes, depreciation & amortization has changed by +$33.01 M (+322.43%)
What is Cellebrite DI quarterly earnings before interest, taxes, depreciation & amortization?
The current quarterly EBITDA of CLBT is $22.07 M
What is the all time high quarterly EBITDA for Cellebrite DI?
Cellebrite DI all-time high quarterly earnings before interest, taxes, depreciation & amortization is $132.06 M
What is Cellebrite DI quarterly EBITDA year-on-year change?
Over the past year, CLBT quarterly earnings before interest, taxes, depreciation & amortization has changed by +$6.21 M (+39.14%)
What is Cellebrite DI TTM earnings before interest, taxes, depreciation & amortization?
The current TTM EBITDA of CLBT is -$155.04 M
What is the all time high TTM EBITDA for Cellebrite DI?
Cellebrite DI all-time high TTM earnings before interest, taxes, depreciation & amortization is $157.69 M
What is Cellebrite DI TTM EBITDA year-on-year change?
Over the past year, CLBT TTM earnings before interest, taxes, depreciation & amortization has changed by -$312.74 M (-198.32%)